Variant report
Variant | nsv508259 |
---|---|
Chromosome Location | chr3:163533756-163553142 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76568684 | chr3:163534423-163534424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551422061 | chr3:163534424-163534425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142474599 | chr3:163534452-163534453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184982595 | chr3:163534529-163534530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576644335 | chr3:163534532-163534533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146563180 | chr3:163534534-163534535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553007398 | chr3:163534560-163534561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189444960 | chr3:163534567-163534568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76343175 | chr3:163534654-163534655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs62293628 | chr3:163534662-163534663 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs10470489 | chr3:163534719-163534720 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs544331296 | chr3:163534744-163534745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550955282 | chr3:163534778-163534779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181227067 | chr3:163534795-163534796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184424989 | chr3:163534796-163534797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7617253 | chr3:163534797-163534798 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs540212109 | chr3:163534866-163534867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560651746 | chr3:163534926-163534927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529590533 | chr3:163534928-163534929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139196200 | chr3:163534962-163534963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570856323 | chr3:163534966-163534967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115350815 | chr3:163534976-163534977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539427348 | chr3:163535026-163535027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574639630 | chr3:163535085-163535086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551481938 | chr3:163535145-163535146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375192551 | chr3:163535150-163535151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75424532 | chr3:163535151-163535152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143234959 | chr3:163535152-163535153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566699799 | chr3:163535156-163535157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150473464 | chr3:163535175-163535176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11708234 | chr3:163539410-163539411 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs560819250 | chr3:163539420-163539421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529852566 | chr3:163539465-163539466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548487458 | chr3:163539466-163539467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76646616 | chr3:163539483-163539484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532101215 | chr3:163539521-163539522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552211058 | chr3:163539559-163539560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565544861 | chr3:163539586-163539587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528060902 | chr3:163539635-163539636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559399004 | chr3:163539644-163539645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548915172 | chr3:163539665-163539666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527683185 | chr3:163539698-163539699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10936366 | chr3:163539705-163539706 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs575776898 | chr3:163539720-163539721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570964683 | chr3:163539734-163539735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184775040 | chr3:163539741-163539742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551626667 | chr3:163539784-163539785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190246600 | chr3:163539812-163539813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539558848 | chr3:163539859-163539860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553384497 | chr3:163539872-163539873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163534400-163535200 | Enhancers | Liver | Liver |
2 | chr3:163539400-163540000 | Enhancers | Fetal Heart | heart |
3 | chr3:163542800-163543200 | Active TSS | Hela-S3 | cervix |
4 | chr3:163543200-163546600 | Weak transcription | Hela-S3 | cervix |
5 | chr3:163546600-163547000 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr3:163546600-163548000 | Active TSS | Hela-S3 | cervix |
7 | chr3:163546800-163547600 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr3:163547200-163547400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr3:163548000-163550000 | Weak transcription | Hela-S3 | cervix |
10 | chr3:163550000-163550200 | Enhancers | Hela-S3 | cervix |